GO:0003723 | RNA binding | 15.07% (11/73) | 2.96 | 0.0 | 6.3e-05 |
GO:0005634 | nucleus | 10.96% (8/73) | 3.4 | 1e-06 | 8.8e-05 |
GO:0043227 | membrane-bounded organelle | 12.33% (9/73) | 3.15 | 1e-06 | 0.000102 |
GO:0043231 | intracellular membrane-bounded organelle | 12.33% (9/73) | 3.15 | 1e-06 | 0.000102 |
GO:0005488 | binding | 54.79% (40/73) | 0.91 | 4e-06 | 0.000257 |
GO:0006397 | mRNA processing | 6.85% (5/73) | 4.3 | 6e-06 | 0.000278 |
GO:0006396 | RNA processing | 9.59% (7/73) | 3.32 | 7e-06 | 0.000281 |
GO:0140657 | ATP-dependent activity | 10.96% (8/73) | 3.13 | 4e-06 | 0.000293 |
GO:0090304 | nucleic acid metabolic process | 15.07% (11/73) | 2.44 | 5e-06 | 0.0003 |
GO:0043170 | macromolecule metabolic process | 30.14% (22/73) | 1.43 | 9e-06 | 0.000321 |
GO:0006139 | nucleobase-containing compound metabolic process | 16.44% (12/73) | 2.23 | 9e-06 | 0.000329 |
GO:0000398 | mRNA splicing, via spliceosome | 5.48% (4/73) | 4.83 | 1.3e-05 | 0.000403 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 5.48% (4/73) | 4.68 | 1.9e-05 | 0.000454 |
GO:0016071 | mRNA metabolic process | 6.85% (5/73) | 4.01 | 1.6e-05 | 0.000459 |
GO:0006807 | nitrogen compound metabolic process | 31.51% (23/73) | 1.33 | 1.8e-05 | 0.000472 |
GO:0000375 | RNA splicing, via transesterification reactions | 5.48% (4/73) | 4.61 | 2.3e-05 | 0.000487 |
GO:0046483 | heterocycle metabolic process | 16.44% (12/73) | 2.09 | 2.2e-05 | 0.000492 |
GO:0016070 | RNA metabolic process | 12.33% (9/73) | 2.59 | 1.8e-05 | 0.000505 |
GO:0006725 | cellular aromatic compound metabolic process | 16.44% (12/73) | 2.04 | 3e-05 | 0.000606 |
GO:1901360 | organic cyclic compound metabolic process | 16.44% (12/73) | 2.01 | 3.6e-05 | 0.0007 |
GO:0008380 | RNA splicing | 5.48% (4/73) | 4.39 | 4.1e-05 | 0.000756 |
GO:0018205 | peptidyl-lysine modification | 4.11% (3/73) | 5.3 | 6.2e-05 | 0.001086 |
GO:0043226 | organelle | 12.33% (9/73) | 2.31 | 8e-05 | 0.001276 |
GO:0043229 | intracellular organelle | 12.33% (9/73) | 2.31 | 8e-05 | 0.001276 |
GO:0051028 | mRNA transport | 2.74% (2/73) | 6.87 | 0.000128 | 0.001816 |
GO:0006406 | mRNA export from nucleus | 2.74% (2/73) | 6.87 | 0.000128 | 0.001816 |
GO:0044238 | primary metabolic process | 32.88% (24/73) | 1.11 | 0.000134 | 0.001843 |
GO:0003676 | nucleic acid binding | 20.55% (15/73) | 1.57 | 0.00012 | 0.00185 |
GO:0034641 | cellular nitrogen compound metabolic process | 16.44% (12/73) | 1.8 | 0.000148 | 0.001953 |
GO:0008270 | zinc ion binding | 9.59% (7/73) | 2.56 | 0.000188 | 0.002411 |
GO:0006405 | RNA export from nucleus | 2.74% (2/73) | 6.45 | 0.000233 | 0.002888 |
GO:0005515 | protein binding | 26.03% (19/73) | 1.25 | 0.000245 | 0.002936 |
GO:0051236 | establishment of RNA localization | 2.74% (2/73) | 6.34 | 0.000275 | 0.002936 |
GO:0036402 | proteasome-activating activity | 2.74% (2/73) | 6.34 | 0.000275 | 0.002936 |
GO:0050658 | RNA transport | 2.74% (2/73) | 6.34 | 0.000275 | 0.002936 |
GO:0050657 | nucleic acid transport | 2.74% (2/73) | 6.34 | 0.000275 | 0.002936 |
GO:0008641 | ubiquitin-like modifier activating enzyme activity | 2.74% (2/73) | 6.04 | 0.000422 | 0.004378 |
GO:0071704 | organic substance metabolic process | 32.88% (24/73) | 0.99 | 0.000476 | 0.00481 |
GO:0008237 | metallopeptidase activity | 4.11% (3/73) | 4.25 | 0.000546 | 0.005373 |
GO:0051168 | nuclear export | 2.74% (2/73) | 5.79 | 0.000599 | 0.00575 |
GO:0043687 | post-translational protein modification | 6.85% (5/73) | 2.82 | 0.000724 | 0.006781 |
GO:0018193 | peptidyl-amino acid modification | 4.11% (3/73) | 4.08 | 0.00076 | 0.006951 |
GO:0016571 | histone methylation | 2.74% (2/73) | 5.45 | 0.000961 | 0.008385 |
GO:0034968 | histone lysine methylation | 2.74% (2/73) | 5.45 | 0.000961 | 0.008385 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 2.74% (2/73) | 5.39 | 0.001043 | 0.008901 |
GO:0008152 | metabolic process | 32.88% (24/73) | 0.9 | 0.001155 | 0.00964 |
GO:0018022 | peptidyl-lysine methylation | 2.74% (2/73) | 5.28 | 0.001217 | 0.009946 |
GO:0009057 | macromolecule catabolic process | 5.48% (4/73) | 3.09 | 0.001273 | 0.010186 |
GO:0004386 | helicase activity | 4.11% (3/73) | 3.8 | 0.001335 | 0.010461 |
GO:0018024 | obsolete histone lysine N-methyltransferase activity | 2.74% (2/73) | 5.18 | 0.001405 | 0.010788 |
GO:0019948 | SUMO activating enzyme activity | 1.37% (1/73) | 9.04 | 0.001904 | 0.013542 |
GO:0016925 | protein sumoylation | 1.37% (1/73) | 9.04 | 0.001904 | 0.013542 |
GO:0008810 | cellulase activity | 1.37% (1/73) | 9.04 | 0.001904 | 0.013542 |
GO:0010265 | SCF complex assembly | 1.37% (1/73) | 9.04 | 0.001904 | 0.013542 |
GO:0003674 | molecular_function | 63.01% (46/73) | 0.46 | 0.002129 | 0.014863 |
GO:0005575 | cellular_component | 20.55% (15/73) | 1.15 | 0.002533 | 0.017369 |
GO:0006479 | protein methylation | 2.74% (2/73) | 4.68 | 0.002795 | 0.018507 |
GO:0008213 | protein alkylation | 2.74% (2/73) | 4.68 | 0.002795 | 0.018507 |
GO:0034518 | RNA cap binding complex | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0005846 | nuclear cap binding complex | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0046073 | dTMP metabolic process | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0004146 | dihydrofolate reductase activity | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0019781 | NEDD8 activating enzyme activity | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0045116 | protein neddylation | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0000339 | RNA cap binding | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0004799 | thymidylate synthase activity | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0006231 | dTMP biosynthetic process | 1.37% (1/73) | 8.04 | 0.003805 | 0.020579 |
GO:0015931 | nucleobase-containing compound transport | 2.74% (2/73) | 4.58 | 0.003213 | 0.020912 |
GO:0004222 | metalloendopeptidase activity | 2.74% (2/73) | 4.42 | 0.00397 | 0.021172 |
GO:0030163 | protein catabolic process | 2.74% (2/73) | 4.51 | 0.003507 | 0.022443 |
GO:0110165 | cellular anatomical entity | 16.44% (12/73) | 1.27 | 0.003687 | 0.023212 |
GO:0006913 | nucleocytoplasmic transport | 2.74% (2/73) | 4.31 | 0.004629 | 0.0237 |
GO:0008186 | ATP-dependent activity, acting on RNA | 2.74% (2/73) | 4.31 | 0.004629 | 0.0237 |
GO:0003724 | RNA helicase activity | 2.74% (2/73) | 4.31 | 0.004629 | 0.0237 |
GO:0051169 | nuclear transport | 2.74% (2/73) | 4.26 | 0.004976 | 0.025142 |
GO:0016570 | histone modification | 2.74% (2/73) | 4.15 | 0.005705 | 0.026081 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 1.37% (1/73) | 7.45 | 0.005702 | 0.026381 |
GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process | 1.37% (1/73) | 7.45 | 0.005702 | 0.026381 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 1.37% (1/73) | 7.45 | 0.005702 | 0.026381 |
GO:0046654 | tetrahydrofolate biosynthetic process | 1.37% (1/73) | 7.45 | 0.005702 | 0.026381 |
GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | 1.37% (1/73) | 7.45 | 0.005702 | 0.026381 |
GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 1.37% (1/73) | 7.45 | 0.005702 | 0.026381 |
GO:0140535 | intracellular protein-containing complex | 4.11% (3/73) | 3.09 | 0.005369 | 0.026773 |
GO:0016043 | cellular component organization | 6.85% (5/73) | 2.1 | 0.00637 | 0.028775 |
GO:0022607 | cellular component assembly | 4.11% (3/73) | 2.95 | 0.007027 | 0.031375 |
GO:0043564 | Ku70:Ku80 complex | 1.37% (1/73) | 7.04 | 0.007596 | 0.031704 |
GO:0005685 | U1 snRNP | 1.37% (1/73) | 7.04 | 0.007596 | 0.031704 |
GO:0042256 | cytosolic ribosome assembly | 1.37% (1/73) | 7.04 | 0.007596 | 0.031704 |
GO:0005737 | cytoplasm | 4.11% (3/73) | 2.93 | 0.007217 | 0.031854 |
GO:0101005 | deubiquitinase activity | 2.74% (2/73) | 3.97 | 0.007301 | 0.031857 |
GO:0097159 | organic cyclic compound binding | 28.77% (21/73) | 0.78 | 0.007391 | 0.031889 |
GO:0019783 | ubiquitin-like protein peptidase activity | 2.74% (2/73) | 3.91 | 0.007945 | 0.032805 |
GO:0046914 | transition metal ion binding | 9.59% (7/73) | 1.59 | 0.008623 | 0.035228 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 1.37% (1/73) | 6.71 | 0.009486 | 0.037169 |
GO:0061578 | K63-linked deubiquitinase activity | 1.37% (1/73) | 6.71 | 0.009486 | 0.037169 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 1.37% (1/73) | 6.71 | 0.009486 | 0.037169 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 1.37% (1/73) | 6.71 | 0.009486 | 0.037169 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0042255 | ribosome assembly | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0019692 | deoxyribose phosphate metabolic process | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0046385 | deoxyribose phosphate biosynthetic process | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0000502 | proteasome complex | 1.37% (1/73) | 6.45 | 0.011372 | 0.0397 |
GO:0043414 | macromolecule methylation | 2.74% (2/73) | 3.71 | 0.01027 | 0.039833 |
GO:0043933 | protein-containing complex organization | 4.11% (3/73) | 2.73 | 0.010681 | 0.040608 |
GO:0071840 | cellular component organization or biogenesis | 6.85% (5/73) | 1.92 | 0.010601 | 0.040707 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:1905819 | negative regulation of chromosome separation | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0032200 | telomere organization | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0007094 | mitotic spindle assembly checkpoint signaling | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0000723 | telomere maintenance | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0006730 | one-carbon metabolic process | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0006874 | intracellular calcium ion homeostasis | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0055074 | calcium ion homeostasis | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0031577 | spindle checkpoint signaling | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0033046 | negative regulation of sister chromatid segregation | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0045839 | negative regulation of mitotic nuclear division | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0051784 | negative regulation of nuclear division | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0051985 | negative regulation of chromosome segregation | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0071174 | mitotic spindle checkpoint signaling | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0071173 | spindle assembly checkpoint signaling | 1.37% (1/73) | 6.04 | 0.015135 | 0.044028 |
GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 1.37% (1/73) | 6.23 | 0.013255 | 0.045856 |
GO:1905818 | regulation of chromosome separation | 1.37% (1/73) | 5.87 | 0.017011 | 0.046658 |
GO:0007088 | regulation of mitotic nuclear division | 1.37% (1/73) | 5.87 | 0.017011 | 0.046658 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.37% (1/73) | 5.87 | 0.017011 | 0.046658 |
GO:0042162 | telomeric DNA binding | 1.37% (1/73) | 5.87 | 0.017011 | 0.046658 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 1.37% (1/73) | 5.87 | 0.017011 | 0.046658 |
GO:0009262 | deoxyribonucleotide metabolic process | 1.37% (1/73) | 5.87 | 0.017011 | 0.046658 |
GO:0046653 | tetrahydrofolate metabolic process | 1.37% (1/73) | 5.87 | 0.017011 | 0.046658 |
GO:2001251 | negative regulation of chromosome organization | 1.37% (1/73) | 5.87 | 0.017011 | 0.046658 |
GO:0016462 | pyrophosphatase activity | 5.48% (4/73) | 2.02 | 0.017243 | 0.046961 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 5.48% (4/73) | 2.11 | 0.014159 | 0.048545 |
GO:0032259 | methylation | 2.74% (2/73) | 3.45 | 0.014533 | 0.049385 |
GO:0016887 | ATP hydrolysis activity | 4.11% (3/73) | 2.42 | 0.018886 | 0.049674 |